Skip to main content

Table 1 The patient’s laboratory findings prior to receiving treatment

From: Severe thrombocytopenia in a patient with inosine triphosphatase (ITPA)–CC genotype caused by pegylated interferon (IFN)-α-2a with ribavirin therapy: a case report

WBC 5800 /μL CRP <0.10 mg/dl
RBC 404 × 104 /μL LDH 238 U/L
Hb 13.5 g/dL UA 5.8 mg/dL
Plt 16.7 × 104 /μL BUN 12.6 mg/dL
PT 11.7 sec Cr 0.52 mg/dL
AST 41 IU/L Na 141 mEq/l
ALT 46 IU/L K 3.8 mEq/l -
TP 7.6 g/dL HBsAg (−) -
Alb 4.4 g/dL HCVAb (+) -
TBIL 0.5 mg/dL HCV-RNA 6.3 LogIU/ml
ALP 248 IU/L Genotype 1B  
γ-GTP 20 IU/L    
  1. WBC, white blood cells; RBC, red blood cells; Plt, platelets; PT, prothrombin time; AST, aspartate aminotransferase; ALT, alanine aminotransferase; TP, total protein; Alb, albumin; TBIL, total bilirubin; ALP, alkaline phosphatase; γ-GTP, gamma glutamyl transpeptidase; CRP, C-reactive protein; LDH, lactate dehydrogenase; UA, uric acid; BUN, blood urea nitrogen; Cr, creatinine; Na, natrium; K, potasium; HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus antibody; HCV-RNA, hepatitis C virus ribonucleic acid.